Yingli Wu

Tangshan College — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

37h-index4.3kcitations193works4.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ubiquitin and proteasome pathways(44), Retinoids in leukemia and cellular processes(27), Acute Myeloid Leukemia Research(22), Chronic Myeloid Leukemia Treatments(18), Protein Degradation and Inhibitors(18)

Publications193 total

Deubiquitinases in liver diseases: from mechanisms to targeted therapy
Science China Life Sciences·2025
Re-Engaging Spinal Reflexes: Toward Multisensory Feedback Integration in Neuroprosthetic Control
Applied and Computational Engineering·2025Open Access
USP2 promotes metabolic dysfunction-associated steatotic liver disease progression via stabilization of PPARγ
Cell Death and Differentiation·2025· 5 cited
Coinhibition of the MEK/RTK pathway has high therapeutic efficacy in KRAS-mutant non-small cell lung cancer
Signal Transduction and Targeted Therapy·2025· 3 citedOpen Access
The diverse functions of ubiquitin-specific protease 47 and its role in diseases
International Journal of Biological Macromolecules·2025
Precise control of float pipe retraction technology in pipe jacking construction
Journal of Physics Conference Series·2025Open Access
A Degradable Multi-Metal-Chelating Stealth Nanoplatform for Dual Ferroptosis/Cuproptosis-Enhanced Metalloimmunotherapy in Leukemia
2025Open Access
Targeting USP2 induces degradation of PML-RARα with or without drug-resistant mutations in acute promyelocytic leukemia
Acta Biochimica et Biophysica Sinica·2025Open Access
CHK1-S, a splicing variant of CHK1, suppresses chronic myeloid leukemia
Leukemia Research·2025
A photothermally triggered cascade bioreactor for cuproptosis and ferroptosis-driven cancer immunotherapy
Journal of Colloid and Interface Science·2025· 3 cited
Targeting USP2 induces degradation of PML-RARα with or without drug-resistant mutations in acute promyelocytic leukemia
2025Open Access
USP24 promotes hepatocellular carcinoma progression by deubiquitinating and stabilizing YAP1
Cancer Cell International·2025· 4 citedOpen Access
Targeting the HuR/E2F7 axis synergizes with bortezomib against multiple myeloma
Acta Pharmacologica Sinica·2025· 2 citedOpen Access
Targeting the RBM39-MEK5 axis synergizes with bortezomib to inhibit the malignant growth of multiple myeloma
Blood Advances·2025· 2 citedOpen Access
Double-edged sword effect of GPX4 in skin homeostasis and diseases
Archives of Dermatological Research·2025· 5 cited
Multi-omic spatial effects on high-resolution AI-derived retinal thickness
Nature Communications·2025· 23 citedOpen Access
Recent advances in cells, nanoparticles, and cell membrane coated nanoparticles for acute myeloid leukemia treatment
Journal of Drug Delivery Science and Technology·2024
Mapping and visualization of global research progress on deubiquitinases in ovarian cancer: a bibliometric analysis
Frontiers in Pharmacology·2024· 2 citedOpen Access
javascript:void(0) Targeting cell death: a potential therapeutic strategy for inflammatory bowel disease and colorectal cancer
2024Open Access
Role of UCHL3 in health and disease
Biochemical and Biophysical Research Communications·2024· 4 cited
page 1 of 10Next →

Frequent Co-authors

Guoqiang Chen(16), Hanzhang Xu(16), Hu Lei(14), Chuanxu Liu(9), Feng‐Hou Gao(9), Weiwei Wang(7), Wei‐Lie Xiao(5), Meng Liu(5), Yin Tong(5), Yunzhao Wu(5), Chunmin Ma(5), Xia Li(4), Han‐Dong Sun(4), Jin Jin(4), Bo Jing(4), Xinhua Xiao(4), Yang Li(4), Li Zhou(4), Hua Yan(4), Wei Wei(4)